Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation NY Valves 2025

LAAC After TAVR: Key Lessons From WATCH TAVR

Presenter: Samir R. Kapadia

June 26, 2025

Presentation NY Valves 2025

Using an Epicardial Approach: CARILLON Updates

Presenter: Samir R. Kapadia

June 26, 2025

Presentation NY Valves 2025

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

LAAC Outcomes in Patients with Prior Structural Heart Interventions

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2025

Latest Clinical Insights: Bridging Evidence and Practice

Presenter: Samir R. Kapadia

June 25, 2025

Presentation NY Valves 2024

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Lifetime Management Considerations

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

How to Mitigate the Risk of Conduction Abnormalities

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Importance of Preserving Coronary Access after TAVI

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Importance of Valve Durability and Avoiding Patient-Prosthesis Mismatch

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Cinching the Dilated LV From the Coronary Sinus Using the CARILLON Device

Presenter: Samir R. Kapadia

June 05, 2024

Presentation NY Valves 2024

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Presenter: Samir R. Kapadia

June 05, 2024

Advertisement

LAAC After TAVR: Key Lessons From WATCH TAVR

Using an Epicardial Approach: CARILLON Updates

Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis

LAAC Outcomes in Patients with Prior Structural Heart Interventions

Latest Clinical Insights: Bridging Evidence and Practice

Patient Selection: From Clinical Trials to “On Label” to Real World – Who Are the Right Candidates for LAAO?

Lifetime Management Considerations

How to Mitigate the Risk of Conduction Abnormalities

Importance of Preserving Coronary Access after TAVI

Importance of Valve Durability and Avoiding Patient-Prosthesis Mismatch

Cinching the Dilated LV From the Coronary Sinus Using the CARILLON Device

Managing a Difficult Triad: RHF, RV Dysfunction, and Severe TR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content